Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_assertion type Assertion NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_head.
- NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_assertion wasGeneratedBy ECO_0000203 NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_provenance.
- NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_assertion wasDerivedFrom befree-2016 NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_provenance.
- NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_assertion SIO_000772 15668896 NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_provenance.
- NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_assertion evidence source_evidence_literature NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_provenance.
- NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_assertion description "[Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477827.RAFv4cooaeC8UUY5f66vSrnl0KIdlHizQFw5IuHv9IkIA130_provenance.